中文 | English
Return
Total: 75 , 1/8
Show Home Prev Next End page: GO
Author:(Zhong-kun XU)

1.Research on ultrafine grinding technology of improving dissolution rates of effective components in Sanjie Zhentong capsule.

Zhong-kun XU ; Jin GAO ; Jian-ping QIN ; Guang-bo CHEN ; Zhen-zhong WANG ; Wei XIAO

China Journal of Chinese Materia Medica 2015;40(10):1945-1947

4.Preliminary investigation of diagnostic value of ultra-high b-value based diffusion-weighted imaging ;in prostate central gland diagnosis

Kun ZHANG ; Xiaojing ZHANG ; Yan ZHONG ; Lu MA ; Haiyi WANG ; Xu ZHANG ; Huiyi YE

Chinese Journal of Radiology 2016;50(5):357-361

5.An excerpt of Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in pregnancy—updated guidelines: Replaces Consult Number 43, November 2017

ZHONG Si-qi ; XU He ; JIANG Liang-kun ; FAN Jing-hua

China Tropical Medicine 2022;22(12):1211-

6.Optimization of one-step pelletization technology of Jiuwei Xifeng granules by response surface methodology.

Xiu-hai WANG ; Xu-fang YANG ; Ye-wen FAN ; Yan-jun ZHANG ; Zhong-kun XU ; Lin-yong YANG ; Zhen-zhong WANG ; Wei XIAO

China Journal of Chinese Materia Medica 2014;39(24):4782-4786

7.Verification of accuracy of multileaf collimator leaf position using a two-dimensional ion chamber array

Zhong-Jian JU ; Yun-Lai WANG ; Lin MA ; Shou-Ping XU ; Xiang-Kun DAI ; Lian-Yuan WANG ;

Chinese Journal of Radiation Oncology 1992;0(04):-

8.Tibial bone transport over an intramedullary nail in combination with antibiotic-loaded calcium sulphate for treatment of segmental bone defect

Yibo XU ; Teng MA ; Qian WANG ; Chen REN ; Deyin LIU ; Ming LI ; Na YANG ; Yao LU ; Liang SUN ; Qiang HUANG ; Hongfei QI ; Zhong LI ; Kun ZHANG

International Journal of Surgery 2021;48(2):97-102,F4

9.A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma

Kun ZHAO ; Yu ZHAO ; Jia-Yi ZHU ; Hui DONG ; Wen-Ming CONG ; Yi YU ; Hui WANG ; Zhong-Zheng ZHU ; Qing XU

Journal of Huazhong University of Science and Technology (Medical Sciences) 2018;38(4):590-596

10.Nadaplatin or cisplatin combined with paclitaxol in treatment for non-small cell lung cancer: a randomized controlled study.

Li-Kun CHEN ; Guang-Chuan XU ; Zhong-Zhen GUAN ; Ying HANG ; Qun-Ying YANG

Chinese Journal of Oncology 2007;29(6):437-440

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 75 , 1/8 Show Home Prev Next End page: GO